TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation

被引：0
|
作者：
Carella, A. M. [1 ]
Palumbo, G. [2 ]
Greco, M. M. [1 ]
Merla, E. [1 ]
Dell'Olio, M. [1 ]
Pisapia, G. [3 ]
Mazza, P. [3 ]
Ferrara, F. [4 ]
Musto, P. [5 ]
Rana, A. [6 ]
Guarini, A. [6 ]
Di Tonno, P. [7 ]
Pastore, D. [8 ]
D'Elia, M. [8 ]
Specchia, G. [8 ]
Capalbo, S. [2 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] United Hosp, Foggia, Italy
[3] Hosp G Moscati, Taranto, Italy
[4] Hosp Cardarelli, Naples, Italy
[5] CROB, Rionero In Vulture, Italy
[6] IRCCS Canc Inst, Bari, Italy
[7] Hosp Di Venere, Bari, Italy
[8] Univ Hematol, Bari, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [1] TEAM (thiotepa, etoposide, cytarabine, melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation
    Carella, A. M.
    Palumbo, G.
    Greco, M.
    Merla, E.
    Dell'Olio, M.
    Scalzulli, P.
    Capalbo, S.
    Pisapia, G.
    Mazza, P.
    Ferrara, F.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S214 - S214
  • [2] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Ferrara, F.
    Greco, M.
    Dell'Olio, M.
    Scalzulli, P.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Iacobazzi, A.
    Musto, P.
    Capalbo, S.
    Cascavilla, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 66 - 66
  • [3] TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) AS CONDITIONING REGIMEN FOR LYMPHOMA TREATMENT WITH AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT)
    Carella, A. M.
    Palumbo, G.
    Merla, E.
    Greco, M.
    Fontana, A.
    Specchia, G.
    Pisapia, G.
    Mazza, P.
    Guarini, A.
    Rana, A.
    Ditonno, P.
    Ferrara, F.
    Musto, P.
    Pastore, D.
    Scime, R.
    Pellegrini, F.
    Capalbo, S.
    Cavallaro, A. Maria
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S177 - S177
  • [4] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
  • [5] Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma
    Zhang, Lihong
    Yang, Haifei
    Qian, Chongsheng
    Zhou, Jihao
    Zhu, Qian
    Jiang, Yibin
    Liu, Shuo
    Chen, Xiaochen
    Xu, Ting
    Qu, Changju
    Li, Caixia
    Jin, Zhengming
    Chu, Jianhong
    Zhang, Xinyou
    Wu, Depei
    Huang, Haiwen
    HEMATOLOGY, 2022, 27 (01) : 404 - 411
  • [6] Tecam (Thiotepa, Etoposide, cyclophosphamide, Cytarabine and Melphalan) Is an Effective and Safe Conditioning Regimen for Autologous Transplant in Lymphoma
    Cohen, Yarden
    Lebel, Eyal
    Zimran, Eran
    Shaulov, Adir
    Stepensky, Polina
    Greenzaid, Sigal Grisariu
    Avni, Batia
    BLOOD, 2022, 140 : 4859 - 4860
  • [7] Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma
    Lin, Meng
    Wu, Xiaolong
    Zhang, Lei
    Li, Ling
    Wang, Xinhua
    Fu, Xiaorui
    Sun, Zhenchang
    Zhang, Xudong
    Zhu, Linan
    Yu, Hui
    Chang, Yu
    Nan, Feifei
    Yan, Jiaqin
    Zhou, Zhiyuan
    Shi, Cunzhen
    Zhang, Mingzhi
    Li, Xin
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 605 - 612
  • [8] TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) is an effective high-dose chemotherapy consolidation regimen with autologous stem cell transplantation for patients with relapsed lymphoma in complete remission
    Pester, F.
    Klink, A.
    Scholl, S.
    Schilling, K.
    Muegge, L.
    Hoeffken, K.
    Sayer, H.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S252 - S252
  • [9] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lim, Sung-Nam
    Lee, Sang Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Sung Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1466 - 1468
  • [10] Busulfan, etoposide, cytarabine and melphalan (BUEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Won-Sik
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Choi, Yun Suk
    Bae, Seong Hwa
    BONE MARROW TRANSPLANTATION, 2019, 54 : 209 - 210
12345